RxSight, Inc. RXST
5.28 USD +0.38 (+7.76%)
At closeNov 12, 2026, 4:01 AM EST
5.32 +0.04 +0.76%
Pre-market · Nov 12, 4:01 AM ET
4.84 Day range 5.29
4.11 52-week range 13.22
- YTD
- -49.33%
- 1 year
- -48.39%
RXST revenue history
Revenue is income from the company’s ordinary business activities.
134,479,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 134,479,000 | -5,448,000 | -3.89% |
| FY 2024 | 2024-12-31 | 139,927,000 | 50,850,000 | 57.09% |
| FY 2023 | 2023-12-31 | 89,077,000 | 40,072,000 | 81.77% |
| FY 2022 | 2022-12-31 | 49,005,000 | 26,412,000 | 116.90% |
| FY 2021 | 2021-12-31 | 22,593,000 | 7,915,000 | 53.92% |
| FY 2020 | 2020-12-31 | 14,678,000 | 12,437,000 | 554.98% |
| FY 2019 | 2019-12-31 | 2,241,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-05T07:00:38.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.